|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.50 USD | -3.16% |
|
-0.74% | -52.73% |
| 07/05 | UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating | MT |
| 07/05 | Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35 | MT |
Company Valuation: QuidelOrtho Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,291 | 5,474 | 5,013 | 2,976 | 1,990 | 920.6 | - | - |
| Change | - | 3.46% | -8.42% | -40.64% | -33.12% | -53.75% | - | - |
| Enterprise Value (EV) 1 | 4,463 | 7,768 | 7,261 | 5,361 | 4,471 | 3,232 | 3,180 | 3,107 |
| Change | - | 74.05% | -6.53% | -26.17% | -16.6% | -27.71% | -1.61% | -2.27% |
| P/E ratio | 7.73x | 8.67x | -500x | -1.47x | -1.76x | -8.44x | -11.1x | -8.43x |
| PBR | 2.75x | 1.12x | 1x | 0.99x | - | 0.5x | 0.53x | 0.54x |
| PEG | - | -0.2x | 5x | -0x | 0x | 0.1x | 0.5x | -0.3x |
| Capitalization / Revenue | 3.12x | 1.68x | 1.67x | 1.07x | 0.73x | 0.34x | 0.33x | 0.31x |
| EV / Revenue | 2.63x | 2.38x | 2.42x | 1.93x | 1.64x | 1.19x | 1.13x | 1.05x |
| EV / EBITDA | 4.48x | 5.84x | 10x | 9.87x | 7.49x | 5.2x | 4.78x | 4.4x |
| EV / EBIT | 4.93x | 9.21x | 52.2x | 16x | 11.8x | 8.88x | 7.4x | 6.5x |
| EV / FCF | 8.7x | 10.4x | 26.9x | -47.8x | -53.9x | 8.57x | 10.6x | 9.86x |
| FCF Yield | 11.5% | 9.58% | 3.71% | -2.09% | -1.86% | 11.7% | 9.4% | 10.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 16.43 | 9.56 | -0.15 | -30.16 | -16.69 | -1.6 | -1.216 | -1.601 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,699 | 3,266 | 2,998 | 2,783 | 2,730 | 2,721 | 2,815 | 2,951 |
| EBITDA 1 | 995.6 | 1,331 | 723.2 | 542.9 | 597 | 621.1 | 664.6 | 706.5 |
| EBIT 1 | 906.1 | 843.7 | 139.1 | 335.8 | 379.3 | 363.8 | 429.5 | 478.3 |
| Net income 1 | 704.2 | 548.7 | -10.1 | -2,027 | -1,132 | -157.5 | -83.07 | -109.2 |
| Net Debt 1 | -828.5 | 2,293 | 2,247 | 2,385 | 2,480 | 2,311 | 2,259 | 2,187 |
| Reference price 2 | 126.97 | 82.89 | 75.03 | 44.25 | 29.30 | 13.50 | 13.50 | 13.50 |
| Nbr of stocks (in thousands) | 41,675 | 66,045 | 66,819 | 67,257 | 67,932 | 68,191 | - | - |
| Announcement Date | 17/02/22 | 15/02/23 | 13/02/24 | 12/02/25 | 11/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.71x | 1.2x | 5.25x | -.--% | 95Cr | |
| 61.88x | 4.86x | 16.22x | 0.35% | 1.69TCr | |
| 37.02x | - | - | 2.19% | 158.67Cr | |
| 18.84x | 2.71x | 9.12x | 2.09% | 114.23Cr | |
| 55.58x | - | - | 0.81% | 57Cr | |
| 45.68x | - | - | - | 45Cr | |
| 19.05x | 2.69x | 11.5x | 1.79% | 40Cr | |
| 138.75x | 20.81x | 129.38x | - | 33Cr | |
| 20.74x | 3.62x | 12.19x | 2.18% | 32Cr | |
| Average | 43.20x | 5.98x | 30.61x | 1.34% | 251.71Cr | |
| Weighted average by Cap. | 54.32x | 4.76x | 16.99x | 0.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- QDEL Stock
- Valuation QuidelOrtho Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition